Muscle toxicity with statins
- 14 December 2009
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 19 (3), 223-231
- https://doi.org/10.1002/pds.1895
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- SLCO1B1 variants and statin-induced myopathy - A genomewide studyThe New England Journal of Medicine, 2008
- SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patientsBritish Journal of Clinical Pharmacology, 2007
- Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapyClinical Therapeutics, 2007
- Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevanceClinical Pharmacology & Therapeutics, 2006
- Transporters as a determinant of drug clearance and tissue distributionEuropean Journal of Pharmaceutical Sciences, 2006
- Pharmacogenomics of human OATP transportersNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2006
- Transporters and drug therapy: Implications for drug disposition and diseaseClinical Pharmacology & Therapeutics, 2005
- Incidence of Hospitalized Rhabdomyolysis in Patients Treated With Lipid-Lowering DrugsJAMA, 2004
- The Organic Anion Transporter (OATP) FamilyDrug Metabolism and Pharmacokinetics, 2004
- Statin‐associated myopathyThe Medical Journal of Australia, 2001